Director
Briggs Morrison, M.D.
Briggs Morrison, M.D., has joined our Board of Directors as of June 2025. Since 2022, he has been Chief Executive Officer and as a member of the Board of Directors at Crossbow Therapeutics, Inc.
He is trained as a medical oncologist with over 30 years of experience in the pharmaceutical and biotechnology industries, and has held executive roles at Syndax Pharmaceuticals, AstraZeneca PLC, Pfizer Inc., and Merck & Co., Inc.
Additionally, he has overseen the clinical development from Phase 1 through to approval and life cycle management of many approved drugs, including Tagrisso®, Imfinzi® and Lynparza®.
Dr. Morrison currently serves on the Board of Directors of a number of public and private biotechnology companies and is an Entrepreneur Partner at MPM BioImpact. He received his B.S. in Biology from Georgetown University and his M.D. from the University of Connecticut.
